Clinical Trial: Molecular Imaging of EpCAM Receptors Using [123I]I-DARPIN-Ec1

U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06386653) titled 'Molecular Imaging of EpCAM Receptors Using [123I]I-DARPIN-Ec1' on April 23.

Brief Summary: The study should evaluate the biological distribution of [123I]I-DARPIN-Ec1 in patients with lung and ovarian cancer

The primary objective are:

* To assess the distribution of [123I]I-DARPIN-Ec1 in normal tissues and tumors at different time intervals.

* To evaluate dosimetry of [123I]I-DARPIN-Ec1 .

* To study the safety and tolerability of the drug [123I]I-DARPIN-Ec1 after a single injection in a diagnostic dosage.

The secondary objective are:

1. To compare the obtained [123I]I-DARPIN-Ec1 SPECT imaging results with the data of CT and/o...